Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 15;13(2):4879-4882.
doi: 10.19102/icrm.2022.130207. eCollection 2022 Feb.

Use of Ambulatory Patch Monitoring Devices to Supplement Inpatient Telemetry-A Descriptive Study of a Single-center Experience During the Coronavirus Disease 2019 Pandemic

Catherine Vanchiere  1 , Stephen McHugh  1 , Ellen Bedenko  2 , Isaac R Whitman  2 , Chethan Gangireddy  2 , Anuj K Basil  2 , Joshua M Cooper  2 , Daniel Edmundowicz  2 , Meredith Brisco-Bacik  2   3 , Edmond M Cronin  2
Affiliations

Use of Ambulatory Patch Monitoring Devices to Supplement Inpatient Telemetry-A Descriptive Study of a Single-center Experience During the Coronavirus Disease 2019 Pandemic

Catherine Vanchiere et al. J Innov Card Rhythm Manag. .

Abstract

To accommodate the surge in patients with coronavirus disease 2019 during the spring of 2020, outpatient areas in our health system were repurposed as inpatient units. These spaces often lacked the same resources as the standard inpatient unit, including telemetry equipment. We utilized mobile cardiac outpatient telemetry (MCOT) in place of traditional telemetry and suggest that MCOT is an appropriate substitution only for patients at low risk of developing arrhythmia given the prolonged time to notification of the care team regarding events and imprecise measurements of the corrected QT interval when compared to 12-lead electrocardiography.

Keywords: Ambulatory monitoring; COVID-19; QT interval; arrhythmia; telemetry.

PubMed Disclaimer

Conflict of interest statement

Dr. Brisco-Bacik receives a salary from and owns stock in GlaxoSmithKline. The other authors report no conflicts of interest for the published content.

References

    1. City of Philadelphia COVID-19 Overview. Testing & Data. Available at: https://www.phila.gov/programs/coronavirus-disease-2019-covid-19/testing.... Accessed November 10, 2020.
    1. Vakili K, Fathi M, Pezeshgi A, et al. Critical complications of COVID-19: a descriptive meta-analysis study. Rev Cardiovasc Med. 2020;21(3):433–442. [CrossRef] [PubMed] - DOI - PubMed
    1. Zylla MM, Merle U, Vey JA, et al. Predictors and prognostic implications of cardiac arrhythmias in patients hospitalized for COVID-19. J Clin Med. 2021;10(1):133. [CrossRef] [PubMed] - DOI - PMC - PubMed
    1. U.S. Food and Drug Administration. Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised) 2020. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents.... Accessed November 10, 2020.
    1. Turakhia MP, Hoang DD, Zimetbaum P, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013;112(4):520–524. [CrossRef] [PubMed] - DOI - PubMed